Symposia: Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Combination therapy, Apoptosis, Fundamental Science, Translational Research, MPN, Drug development, Bispecific Antibody Therapy, Genomics, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Non-Biological therapies, Metabolism, Myeloid Malignancies, Biological Processes, Molecular biology, Technology and Procedures, Pathogenesis
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Combination therapy, Apoptosis, Fundamental Science, Translational Research, MPN, Drug development, Bispecific Antibody Therapy, Genomics, Chronic Myeloid Malignancies, Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Non-Biological therapies, Metabolism, Myeloid Malignancies, Biological Processes, Molecular biology, Technology and Procedures, Pathogenesis
Monday, December 9, 2024: 2:45 PM-4:15 PM
Seaport Ballroom ABCD
(Manchester Grand Hyatt San Diego)
Moderators:
Yana Pikman, MD, Dana-Farber Cancer Institute and Boston Children's Hospital
and
Paolo Gallipoli, MD, ARRAY(0xd690dc0)
Disclosures:
Gallipoli: Astellas: Honoraria; GSK: Other: Spouse works for GSK.
3:00 PM
3:15 PM
3:30 PM
3:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH